AR107223A1 - DIRECTED ANTIBODIES AGAINST UPK1B AND METHODS FOR USE - Google Patents

DIRECTED ANTIBODIES AGAINST UPK1B AND METHODS FOR USE

Info

Publication number
AR107223A1
AR107223A1 ARP160104000A ARP160104000A AR107223A1 AR 107223 A1 AR107223 A1 AR 107223A1 AR P160104000 A ARP160104000 A AR P160104000A AR P160104000 A ARP160104000 A AR P160104000A AR 107223 A1 AR107223 A1 AR 107223A1
Authority
AR
Argentina
Prior art keywords
upk1b
methods
antibodies against
directed antibodies
antibody
Prior art date
Application number
ARP160104000A
Other languages
Spanish (es)
Inventor
Robert A Stull
David Coelho
Earl Kim
Zhao Huang
Sam Williams
Marianne Santaguida
Wade Anderson
Sarah Fong
Kristen Mknight
Original Assignee
Abbvie Stemcentrx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Stemcentrx Llc filed Critical Abbvie Stemcentrx Llc
Publication of AR107223A1 publication Critical patent/AR107223A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anticuerpos anti-UPK1B y conjugados de anticuerpo y fármaco, y métodos para el uso de los mencionados anticuerpos y conjugados de anticuerpo y fármaco anti-UPK1B para tratar el cáncer. Reivindicación 2: Un anticuerpo aislado que se une a UPK1B humana caracterizado porque comprende la SEQ ID Nº 1.Anti-UPK1B antibodies and antibody and drug conjugates, and methods for the use of said antibodies and anti-UPK1B antibody and drug conjugates to treat cancer. Claim 2: An isolated antibody that binds to human UPK1B characterized in that it comprises SEQ ID No. 1.

ARP160104000A 2015-12-22 2016-12-22 DIRECTED ANTIBODIES AGAINST UPK1B AND METHODS FOR USE AR107223A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562270993P 2015-12-22 2015-12-22

Publications (1)

Publication Number Publication Date
AR107223A1 true AR107223A1 (en) 2018-04-11

Family

ID=62103987

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160104000A AR107223A1 (en) 2015-12-22 2016-12-22 DIRECTED ANTIBODIES AGAINST UPK1B AND METHODS FOR USE

Country Status (1)

Country Link
AR (1) AR107223A1 (en)

Similar Documents

Publication Publication Date Title
CO2018010458A2 (en) Anti-tim-3 antibodies and compositions
CY1125260T1 (en) TIGIT COMMITMENT FACTORS AND THEIR USES
GT201700102A (en) ANTIBODY-DRUG CONJUGATES
CY1122721T1 (en) ANTIBODIES THAT BIND ACL
AR107442A1 (en) ANTIBODIES AGAINST THE ORPHANE RECEPTOR SIMILAR TO THE THIROSINE QUINASE 1 (ANTI-ROR1) RECEPTOR, BISPECIFIC ANTIBODIES THAT JOIN ROR1 AND THE CD3 ANTIGEN, AND METHODS FOR TREATMENT OF CANCER
CL2018003758A1 (en) Anti-dll3-antibody antibody conjugates and methods of use. (divisional application 201800458)
CL2018002012A1 (en) Maitansinoid derivatives, conjugates thereof and methods of use.
CL2016001723A1 (en) Antibody molecule that binds to the programmed death receptor 1 (pd-1) and uses.
PH12017502390A1 (en) Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof
CL2017000250A1 (en) Anti-ctla4 monoclonal antibody or its antigen binding fragment, a pharmaceutical composition and use
AR101846A1 (en) ANTI-CLL-1 ANTIBODIES AND IMMUNOCATE PLAYERS
PH12016502061A1 (en) Novel antii-rnf43 antibodies and methods of use
BR112015013127A2 (en) immunotherapy with binding agents
CL2018001722A1 (en) New anti-mfi2 antibodies and methods of use (divisional application 201700506)
MA40513A (en) Anti-cdh6 antibody drug conjugates
BR112017013111A2 (en) methods of treating a disorder and treating synovitis, use of an antibody and antibody
BR112018010279A2 (en) new anti-emr2 antibodies and methods of use
PE20171060A1 (en) ANTI-CLDN CHEMERICAL RECEPTORS AND METHODS OF USE
ES2721935T3 (en) Anti-BAG3 antibodies for therapeutic use
BR112018012884A2 (en) new anti-mmp16 antibodies and methods of use
MX2018013484A (en) Novel anti-tnfrsf21 antibodies and methods of use.
BR112018012883A2 (en) new anti-upk1b antibodies and methods of use
AR093227A1 (en) IMMUNOCONJUGADOS AND ANTIBODIES AGAINST THE ENDOTHELINE B RECEIVER (ANTI-ETBR)
AR107223A1 (en) DIRECTED ANTIBODIES AGAINST UPK1B AND METHODS FOR USE
AR102495A1 (en) ANTIBODIES AGAINST DOMAIN 3 OF THE IMMUNOGLOBULIN AND MUCINE OF LYMPHOCYT T (TIM3) AND METHODS OF USE

Legal Events

Date Code Title Description
FB Suspension of granting procedure